JRGE:XETRA:XETRA-JPMorgan ETFs (Ireland) ICAV - Global Research Enhanced Index Equity UCITS ETF EUR Hedged Acc (EUR)

ETF | Others |

Last Closing

USD 45.315

Change

+0.16 (+0.34)%

Market Cap

USD 0.02B

Volume

433.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-10 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.16 (+0.29%)

USD 445.28B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

N/A

USD 191.96B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.03 (-0.10%)

USD 177.46B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.09 (+0.30%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.25 (+0.98%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

+0.35 (+0.75%)

USD 102.61B
8R80:XETRA Amundi Index Solutions - Amund..

+0.74 (+0.53%)

USD 98.84B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.18 (+0.35%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.68 (+0.63%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+3.84 (+0.62%)

USD 80.38B

ETFs Containing JRGE:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.66% 41% F 41% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.66% 41% F 41% F
Trailing 12 Months  
Capital Gain 16.93% 65% D 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 16.93% 64% D 63% D
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 10.98% 67% D+ 66% D+
Dividend Return 10.98% 66% D+ 65% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.47% 56% F 65% D
Risk Adjusted Return 95.76% 82% B 84% B
Market Capitalization 0.02B 12% F 11% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.